QuantView GmbH

QuantView GmbH specializes in advancing MRI technology through revolutionary signal amplification methods, utilizing a quantum mechanical technique for enhanced image resolution. By focusing on hyperpolarized MRI technology, QuantView significantly improves the visualization of human metabolism, aiding in the early detection of metabolic-related diseases such as cancer. Their innovative contrast agent, which is based on pyruvate, enhances the ability to detect pathological changes at a cellular level, thus improving treatment effectiveness. This approach offers up to 30,000 times signal enhancement with the potential for up to 70,000 times, setting a new standard in early diagnostic imaging. QuantView`s synthesis process achieves yields as high as 70%, far surpassing competitors, and their commitment to transparency is evident in their full disclosure of the contrast agent`s structure and properties.